Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
This study has been completed.
Sponsor:
Hadassah Medical Organization
Collaborators:
Institut für Klinische und Molekulare Virologie
University of Erlangen-Nürnberg Medical School
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00284687
First received: January 31, 2006
Last updated: June 9, 2010
Last verified: August 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |